ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q2Scopus Q2SCImago #6,175Gold OA

Therapeutic Advances in Cardiovascular Disease

Identifier (ISSN):1753-9447(Print)/1753-9455(Online)
•
Publisher:SAGE Publishing
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
3.3↑ +1.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Therapeutic Advances in Cardiovascular Disease

WoS Q2
12452.320232.620242.220253.32026
Annual Impact Factor Metric
Current (2026):3.3
Scopus SJR & RankScopus Q2
0.862
#6,175

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
44

44 papers with at least that number of citations each

WoS: ESCIQ2
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
9articles/year
100% Gold OA•53.85% Original Research

Aims & Scope

The journal is aimed at clinicians and researchers from the cardiovascular disease field and will be a forum for all views and reviews relating to this discipline.Topics covered will include: ·arteriosclerosis ·cardiomyopathies ·coronary artery disease ·diabetes ·heart failure ·hypertension ·metabolic syndrome ·obesity ·peripheral arterial disease ·stroke ·arrhythmias ·genetics

Topics Covered (Recognized by AI)
MedicineInternal medicine96.7%Biology79.2%Cardiology71.9%Endocrinology57.5%Radiology50.2%Pathology50.2%Chemistry45.4%Psychology43.1%Biochemistry41.2%Psychiatry40.3%Surgery39.2%Blood pressure34.1%Genetics31.9%Myocardial infarction24.1%Intensive care medicine23.5%Pharmacology23%Physics20.6%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Q2
Rank81/237
IndexESCI
JCIESCI2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Q3
Rank120/237
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.3
Articles / Year18
Total Citations4
2025
IF2.2
Articles / Year14
Total Citations19
2024
IF2.6
Articles / Year28
Total Citations220
2023
IF2.3
Articles / Year17
Total Citations158
2022
IF—
Articles / Year13
Total Citations130

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,175Scopus Q2SCImago Profile
Scopus Coverage:2007-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.862

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.39

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,136 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations171
3-Year Documents57
Citable Documents55

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate25.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cardiology and Cardiovascular MedicineQ2
Pharmacology (medical)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区CARDIAC & CARDIOVASCULAR SYSTEMS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Advances in Cardiovascular Disease (ISSN: 1753-9447) is a peer-reviewed international scholarly journal in the field of CARDIAC & CARDIOVASCULAR SYSTEMS, published by SAGE Publishing in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 3.30, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 0.862 (Q2), an H-index of 44.

The journal enforces rigorous peer evaluation with an annual output of approximately 9 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,136 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
SAGE Publishing
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b3ffdf28-b3b3-4c82-906b-818639d43fbb
Database Updated: 2026-10-01